Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI (ADONIS-PCI)
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)
Sponsor: Bielanski Hospital
A PHASE4 clinical study on Acute Coronary Syndrome and Antithrombotic Therapy, this trial is actively recruiting participants. The trial is conducted by Bielanski Hospital and has accumulated 7 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Sep 2023 — Jul 2024 [monthly]
Recruiting PHASE4
-
Apr 2023 — Sep 2023 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
Dec 2021 — Apr 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bielanski Hospital
- Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
- Medical University of Gdansk
- Medical University of Lublin
- Medical University of Silesia
- Medical University of Warsaw
- Medical University of Łódź
- Military Institute od Medicine National Research Institute
- National Institute of Cardiology, Warsaw, Poland
- Nicolaus Copernicus University
- Pomeranian Medical University Szczecin
- Poznan University of Medical Sciences
- University of Opole, Poland
- Voivode Specialist Hospital in Olsztyn, Poland
- Voivodeship Hospital, Kielce, Poland
For direct contact, visit the study record on ClinicalTrials.gov .